Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
FBT vs FBDIX
Shared holdings
8
FBT covered by FBDIX
22.43%
FBDIX covered by FBT
22.43%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 32 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
FBT (March 31, 2026)
| Security | Weight | |
|---|---|---|
| MODERNA INC | 5.26% | |
| UNITED THERAPEUTICS CORP DEL | 4.36% | |
| ALKERMES PLC | 4.23% | |
| GILEAD SCIENCES INC | 4.09% | |
| AXSOME THERAPEUTICS INC | 3.88% | |
| AMGEN INC | 3.83% | |
| CORCEPT THERAPEUTICS INC | 3.82% | |
| KRYSTAL BIOTECH INC | 3.51% | |
| BIOGEN INC | 3.47% | |
| EXELIXIS INC | 3.46% | |
| NEUROCRINE BIOSCIENCES INC | 3.44% | |
| REGENERON PHARMACEUTICALS INC | 3.44% | |
| VERTEX PHARMACEUTICALS INC | 3.42% | |
| BIOMARIN PHARMACEUTICAL INC | 3.40% | |
| ARGENX SE SPONSORED ADR | 3.29% | |
| SAREPTA THERAPEUTICS INC | 3.24% | |
| HALOZYME THERAPEUTICS INC | 3.17% | |
| BIONTECH SE ADR | 3.16% | |
| INCYTE CORP | 3.13% | |
| BEONE MEDICINES LTD ADR | 3.12% | |
| ILLUMINA INC | 3.10% | |
| NATERA INC | 3.03% | |
| ACADIA PHARMACEUTICALS INC | 2.95% | |
| ALNYLAM PHARMACEUTICALS INC | 2.95% | |
| BIO-TECHNE CORP | 2.82% | |
| GENMAB A/S -SP ADR DEPOSITARY RECEIPT | 2.78% | |
| VERACYTE INC | 2.72% | |
| REPLIGEN CORP | 2.51% | |
| BRUKER CORP | 2.35% | |
| NEOGENOMICS INC | 2.00% | |
| DREY-GVT CSH-I | 0.06% | |
| DAIWA CAPITAL MARKETS AMERICA INC | 0.01% |
FBDIX (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| GILEAD SCIENCES INC | 5.99% | |
| AMGEN INC | 4.67% | |
| VERTEX PHARMACEUTICALS INC | 4.57% | |
| JAZZ PHARMA PLC | 4.43% | |
| REGENERON PHARMACEUTICALS INC | 4.31% | |
| ARGENX SE SPONSORED ADR | 3.92% | |
| Franklin Institutional U.S. Government Money Market Fund | 3.36% | |
| PRAXIS PRECISION MEDICINES INC | 3.13% | |
| INSMED INC | 2.82% | |
| Ascendis Pharma A/S | 2.79% | |
| GUARDANT HEALTH INC | 2.70% | |
| PTC THERAPEUTICS INC | 2.66% | |
| TERNS PHARMACEUTICALS INC | 2.54% | |
| ALNYLAM PHARMACEUTICALS INC | 2.15% | |
| MIRUM PHARMACEUTICALS INC | 2.11% | |
| STRUCTURE THERAPEUTICS INC ADR | 1.92% | |
| REVOLUTION MEDICINES INC | 1.87% | |
| MINERALYS THERAPEUTICS INC | 1.83% | |
| ASTRAZENECA PLC SPONS ADR | 1.81% | |
| NEUROCRINE BIOSCIENCES INC | 1.75% | |
| Abivax SA SPONSORED ADS | 1.74% | |
| EYEPOINT PHARMACEUTICALS INC | 1.63% | |
| IONIS PHARMACEUTICALS INC | 1.62% | |
| BRIDGEBIO PHARMA INC | 1.53% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 1.44% | |
| LILLY ELI and CO | 1.39% | |
| OLEMA PHARMACEUTICALS INC | 1.37% | |
| ARCUTIS BIOTHERAPEUTICS INC | 1.22% | |
| SPYRE THERAPEUTICS INC | 1.21% | |
| BENITEC BIOPHARMA INC | 1.15% | |
| SYNDAX PHARMACEUTICALS INC | 1.12% | |
| CG ONCOLOGY INC | 1.10% | |
| ORUKA THERAPEUTICS INC | 1.09% | |
| DIANTHUS THERAPEUTICS INC | 1.03% | |
| CONTINEUM THERAPEUTICS INC CL A | 0.92% | |
| DYNE THERAPEUTICS INC | 0.88% | |
| ARS PHARMACEUTICALS INC | 0.86% | |
| Franklin Institutional US Government Money Market Fund | 0.84% | |
| NUVALENT INC-A | 0.74% | |
| SOLENO THERAPEUTICS INC | 0.67% | |
| ACHIEVE LIFE SCIENCES INC | 0.63% | |
| BICARA THERAPEUTICS INC | 0.62% | |
| AMYLYX PHARMACEUTICALS INC | 0.60% | |
| ALTO NEUROSCIENCE INC | 0.60% | |
| UNIQURE N.V. | 0.59% | |
| NEWAMSTERDAM PHARMA COMPANY NV | 0.56% | |
| TANGO THERAPEUTICS INC | 0.54% | |
| INVENTIVA SA UNSPON ADR | 0.53% | |
| APOGEE THERAPEUTICS INC | 0.52% | |
| ORIC PHARMACEUTICALS INC | 0.51% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.